^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Xpert® Bladder Cancer Monitor

Company:
Danaher Corp
Type:
CE Marked
Related tests:

Details

Evidence
Xpert Bladder Cancer Monitor, is a qualitative in vitro diagnostic test designed to monitor for the recurrence of bladder cancer in patients previously diagnosed with bladder cancer.The test utilizes a voided urine specimen and measures the levels of five targetmRNAs (ABL1, CRH, IGF2, UPK1B, ANXA10) by means of real-time, reverse transcription-polymerase chain reaction (RT-PCR). The Xpert Bladder Cancer Monitor is indicated as an aid to standard clinical evaluation in monitoring for bladder cancer recurrence in patients previously diagnosed with bladder cancer and should be used in conjunction with other clinical measures to assess disease recurrence.
Cancer:
Bladder Cancer
Gene:
ABL1 (ABL proto-oncogene 1), ANXA10 (Annexin A10), IGF2 (Insulin-like growth factor 2), UPK1B (Uroplakin 1B)
Method:
RT-PCR
Approvals
Date
Cancer
Gene
Drug
By
10/06/16
CE
Confirmatory trial(s)